Dyskeratosis Congenita Autosomal Recessive 8 C5774257
An autosomal recessive form of bone marrow failure characterized by skin abnormalities, nail dystrophy, and white patches in the mouth. Both males and females can be affected. Treatment involves supportive care and monitoring for complications.
Key facts at a glance
- ICD-10
- Q84.9
- ICD-11
- LA00.0
- Body system
- dermatologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(dermatologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Hematopoietic Stem Cell Transplantation
HSCT remains the cornerstone treatment for bone marrow failure in autosomal recessive dyskeratosis congenita subtype 8. This subtype may have specific phenotypic variations requiring individualized approach.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Pulmonary Function Monitoring
Regular pulmonary function testing and imaging to detect interstitial lung disease or pulmonary fibrosis, which represent major sources of morbidity in dyskeratosis congenita.
Additional treatment options
Antifibrotic Agents
Pirfenidone or nintedanib may be considered for patients developing pulmonary fibrosis, though experience in dyskeratosis congenita is limited and should be guided by specialist consultation.
medicationSmoking Cessation and Environmental Avoidance
Complete avoidance of tobacco smoke, occupational lung irritants, and air pollution to prevent additional pulmonary insult in patients with or at risk for pulmonary complications.
lifestylePulmonary Rehabilitation
Supervised exercise training, breathing exercises, and education programs designed to maintain pulmonary function and improve exercise tolerance in patients with established lung disease.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Dyskeratosis Congenita Autosomal Recessive 8 C5774257?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Dyskeratosis Congenita Autosomal Recessive 8 C5774257. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy